
Results
9
Stocks which the market has priced substantially different to their cash flows, which could imply risk.
9 companies
PharmaResearch
Market Cap: ₩4.1t
Operates as a biopharmaceutical company primarily in South Korea.
A214450
₩413,500.00
7D
-2.8%
1Y
-39.2%
Oscotec
Market Cap: ₩1.5t
Operates as a biotechnology company, engages in the drug development, functional materials and related products, and dental bone graft material businesses.
A039200
₩38,850.00
7D
1.4%
1Y
22.0%
Daewoong Pharmaceutical
Market Cap: ₩1.4t
Develops, manufactures and commercializes pharmaceutical products in South Korea and internationally.
A069620
₩121,400.00
7D
-1.5%
1Y
-9.4%
JW Holdings
Market Cap: ₩281.6b
Operates as a healthcare company in South Korea, the United States, Japan, China, and internationally.
A096760
₩4,070.00
7D
1.0%
1Y
23.3%
Chong Kun Dang Holdings
Market Cap: ₩184.7b
Manufactures and distributes pharmaceutical products in South Korea and internationally.
A001630
₩38,900.00
7D
-2.5%
1Y
-17.0%
Ilyang PharmaceuticalLtd
Market Cap: ₩149.7b
Operates as a pharmaceutical company primarily in South Korea.
A007570
₩8,350.00
7D
-4.0%
1Y
-34.1%
Sinsin Pharmaceutical
Market Cap: ₩67.6b
Manufactures and sells pharmaceutical products in South Korea.
A002800
₩4,445.00
7D
0.3%
1Y
-21.2%
RP Bio
Market Cap: ₩52.7b
A bio-health company, engages in the research, development, manufacture, and sale of soft capsules in Korea and internationally.
A314140
₩5,800.00
7D
-8.1%
1Y
-5.5%
Korean Drug
Market Cap: ₩36.7b
Manufactures and sells medicines for treating various diseases in South Korea.
A014570
₩3,400.00
7D
-2.7%
1Y
-26.9%